Data as of Apr 17
| -0.53 / -0.92%|
The 15 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 61.00, with a high estimate of 73.00 and a low estimate of 55.00. The median estimate represents a +6.85% increase from the last price of 57.09.
The current consensus among 20 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.